(Q33504302)

English

Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days.

scientific article

Statements

Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit